GILD
Gilead Sciences, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #43
- Final score
- 69.57
- Years on list
- 6
↗ Climbed 139 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- GILD· Gilead Sciences, Inc.
- ILMN· Illumina, Inc.
- BIIB· Biogen Inc.
Figure 01 · Side-by-side summary
The headline numbers
ILMN
Illumina, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #40
- Final score
- 69.66
- Years on list
- 6
↗ Climbed 490 since 2020
BIIB
Biogen Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #59
- Final score
- 68.00
- Years on list
- 6
↗ Climbed 3 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | GILD | ILMN | BIIB |
|---|---|---|---|
| Climate Change | 82.3 | 92.8 | 92.1 |
| Employee Relations | 77.8 | 57.2 | 67.8 |
| Environment | 67.9 | 69.9 | 59.2 |
| Stakeholders & Society | 74.4 | 77.7 | 69.9 |
| Human Rights | 41.7 | 55.7 | 52.9 |
| Governance | 54.7 | 51.7 | 47.7 |
| Performance Rating | 59.3 | 57.3 | 59.9 |